Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
The renewed NCIB allows Baytex to purchase up to 70.112 million common shares during the 12-month period commencing July 2, 2024 and ending July 1, 2025 or such earlier time as the NCIB is completed or terminated at the option of Baytex.
Posted In: BTE